1. “Assessment of the Safety and Efficacy of dupilumab in Children with Asthma (Liberty Asthma Excursion) - Full Text View.”Full Text View - ClinicalTrials.gov, clinicaltrials.gov/ct2/show/NCT03560466. Browsed on 15/06/2019.
2. “Asthma.” World Health Organization, World Health Organization, www.who.int/en/news-room/fact-sheets/detail/asthma. Browsed on 04/06/2019.
3. “Continuation of TRAVERSE- LTS12551 Evaluating dupilumab Safety in Patients with Asthma (Long-Term Follow-Up) - Full Text View.”Full Text View - ClinicalTrials.gov, clinicaltrials.gov/ct2/show/NCT03620747. Browsed on 13/06/2019.
4. “Drugs@FDA: FDA Approved Drug Products.”Accessdata.fda.gov, www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=761055Browsed on 24/05/2019.
5. “Efficacy and Safety Study of dupilumab in Patients with Persistent Asthma - Full Text View.”Full Text View - ClinicalTrials.gov, clinicaltrials.gov/ct2/show/NCT03782532. Browsed on 15/06/2019.